Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 6Lymphoid 4Myeloid 2Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 3Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Uveal Melanoma 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Multiple Myeloma 1Mesothelioma 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Lymphoma 1Leukemia, Prolymphocytic, T-Cell 1Leukemia, Myeloid, Acute 1Leukemia 1Immunoblastic Lymphadenopathy 1Graft vs Host Disease 1

Interventions

Cyclophosphamide 12Tacrolimus 11Antilymphocyte Serum 9Peripheral Blood Stem Cell Transplantation 7Mycophenolic Acid 7Methylprednisolone 7Methotrexate 7Cyclosporine 7Busulfan 7fludarabine phosphate 6Filgrastim 6Whole-Body Irradiation 5Sirolimus 5Etoposide 5Radiotherapy 3Melphalan 3Rituximab 2Prednisone 2Immunosuppression Therapy 2Flow Cytometry 2Cord Blood Stem Cell Transplantation 2Biopsy 2Beclomethasone 2Amplified Fragment Length Polymorphism Analysis 2thymoglobulin 1sargramostim 1ruxolitinib 1rasburicase 1merphos 1fludarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × ruxolitinib × Dermatologic × Clear all
NCT07356245 2026-04-15

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
44 enrolled
DermatologicLymphoidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡